R&D

Eli Lilly funds aim to share research costs
FT.com
Mon, 02/14/11 - 11:22 am
Eli Lilly
R&D
Drug Firms Must Swallow Bitter Pill
WSJ Online
Fri, 02/11/11 - 12:16 pm
Big Pharma
innovation
R&D
Merck Plans $8.1 Billion-$8.5 Billion R&D, Daily Says
Bloomberg
Fri, 02/11/11 - 11:59 am
R&D
Merck
Novartis Institute Tackles Unprofitable Drugs
Forbes
Mon, 02/7/11 - 07:22 pm
Novartis
R&D
Lilly Ties Employee Bonus To R&D Pipeline
Pharmalot
Mon, 02/7/11 - 08:45 am
Eli Lilly
bonuses
R&D
Pfizer To Shrink R&D And Cut Up To 3,500 Jobs
Pharmalot
Tue, 02/1/11 - 11:20 am
Pfizer
layoffs
R&D
Pfizer Embraces New Model for Drug Development
Seeking Alpha
Sun, 01/30/11 - 12:11 pm
Pfizer
R&D
Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
Yahoo
Fri, 01/28/11 - 09:40 am
Endo
Orion
R&D
cancer
INTERVIEW: AstraZeneca R&D Chief Seeks Alliances, In-Licensing
WSJ Online
Mon, 01/24/11 - 12:49 pm
AstraZeneca
R&D
in-licensing
The WHO, A Novartis Exec & A Conflict Of Interest
Pharmalot
Thu, 01/20/11 - 09:52 am
WHO
Novartis
R&D
Novartis R&D strategy keeps marketers on the sidelines
Fierce Biotech
Tue, 01/4/11 - 10:07 am
Novartis
R&D
AstraZeneca's Brennan Poaches Pfizer to Rebuild Research
Bloomberg
Wed, 12/29/10 - 10:47 am
Pfizer
R&D
AstraZeneca
David Brennan
Pharma CEOs
Takeovers Vs. R&D: What Will Drive Biotech Stocks in 2011?
Seeking Alpha
Tue, 12/28/10 - 02:08 pm
R&D
biotech
M&A
Cepheid
Abbott Laboratories
Bristol-Myers Squibb
Dendreon
Elan
Biogen Idec
JNJ
King
Neurocrine
Pfizer
SPDR Biotech
Pfizer's Asia Head of R&D Leaves for AstraZeneca
Seeking Alpha
Mon, 12/13/10 - 08:31 pm
Pfizer
Asia
R&D
AstraZeneca
Bayer to keep R&D expenses at 3.1 bln eur in 2011
Reuters
Wed, 12/8/10 - 02:17 pm
Bayer
R&D
New Approach to Research by Pharmaceutical Company (Pfizer)
Sciblogs
Sun, 12/5/10 - 12:26 pm
Pfizer
R&D
Analyst Recap: Swiss Drugmaker Novartis Has Strong Pipeline
Seeking Alpha
Tue, 11/23/10 - 10:38 am
Novartis
pipelines
emerging markets
R&D
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
The Orphanization of Drug Development
Minyanville
Fri, 11/19/10 - 11:22 am
drug development
R&D
orphan drugs
Top 15 Pharma R&D Budgets
Fierce Pharma
Thu, 11/18/10 - 08:47 am
R&D
Roche
Pfizer
Novartis
JNJ
Sanofi
GSK
Merck
Takeda
AstraZeneca
Eli Lilly
Boehringer Ingelheim
Bristol-Myers Squibb
Abbott Laboratories
Daiichi Sankyo
Astellas

Pages